2015 | Identification of a subnuclear body involved in sequence-specific cytokine RNA processing | NATURE COMMUNICATIONS |
2017 | Identification of genetic susceptibility loci for intestinal Behçet's disease
| SCIENTIFIC REPORTS |
2010 | Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study | JOURNAL OF CLINICAL GASTROENTEROLOGY |
2012 | Interactions between IL17A, IL23R, and STAT4 polymorphisms confer susceptibility to intestinal Behcet's disease in Korean population | LIFE SCIENCES |
2017 | Interleukin-33 regulates intestinal inflammation by modulating macrophages in inflammatory bowel disease
| SCIENTIFIC REPORTS |
2023 | Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Behçet's disease
| ARTHRITIS RESEARCH & THERAPY |
2019 | Lactobacillus acidophilus suppresses intestinal inflammation by inhibiting endoplasmic reticulum stress | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2020 | Lactobacillus plantarum CBT LP3 ameliorates colitis via modulating T cells in mice
| INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY |
2020 | Melatonin controls microbiota in colitis by goblet cell differentiation and antimicrobial peptide production through Toll-like receptor 4 signalling
| SCIENTIFIC REPORTS |
2020 | Nanocomposites-based targeted oral drug delivery systems with infliximab in a murine colitis model
| JOURNAL OF NANOBIOTECHNOLOGY |
2024 | New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases
| THERAPEUTIC ADVANCES IN GASTROENTEROLOGY |
2023 | Novel Histone Deacetylase 6 Inhibitor Confers Anti-inflammatory Effects and Enhances Gut Barrier Function
| GUT AND LIVER |
2022 | Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function
| FRONTIERS IN IMMUNOLOGY |
2023 | Olfactomedin 4 produces dysplasia but suppresses metastasis of colon cancer | CANCER GENE THERAPY |
2011 | Potential anti-cancer activity of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a histone deacetylase inhibitor, against breast cancer both in vitro and in vivo | CANCER SCIENCE |
2018 | Protective effects of guggulsterone against colitis are associated with the suppression of TREM-1 and modulation of macrophages | AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY |
2017 | Proteomic Analysis of Serum Amyloid A as a Potential Marker in Intestinal Behçet's Disease | DIGESTIVE DISEASES AND SCIENCES |
2019 | Proteomics-based functional studies reveal that galectin-3 plays a protective role in the pathogenesis of intestinal Behçet's disease
| Scientific Reports |
2011 | Relationships between genetic polymorphisms of triggering receptor expressed on myeloid cells-1 and inflammatory bowel diseases in the Korean population | LIFE SCIENCES |
2021 | Succinate-treated macrophages attenuate dextran sodium sulfate colitis in mice
| INTESTINAL RESEARCH |
2018 | Survival of Cancer Stem-Like Cells Under Metabolic Stress via CaMK2α-mediated Upregulation of Sarco/Endoplasmic Reticulum Calcium ATPase Expression | CLINICAL CANCER RESEARCH |
2019 | Synergistic Activity of Paclitaxel, Sorafenib, and Radiation Therapy in advanced Renal Cell Carcinoma and Breast Cancer
| Translational Oncology |
2012 | Synthesis and biological evaluation of 2-benzylamino-4(5)-(6-methylpyridin-2-yl)-5(4)-([1,2,4]triazolo[1,5-a]-pyridin-6-yl)thiazoles as transforming growth factor-beta type 1 receptor kinase inhibitors | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY |
2015 | The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells
| BMC CANCER |
2016 | The Correlation of Serum IL-12B Expression With Disease Activity in Patients With Inflammatory Bowel Disease
| MEDICINE |
2015 | The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells
| BMC CANCER |
2021 | Triggering Receptor Expressed on Myeloid Cells-1 Agonist Regulates Intestinal Inflammation via Cd177 + Neutrophils
| FRONTIERS IN IMMUNOLOGY |
2016 | TRIM31 promotes Atg5/Atg7-independent autophagy in intestinal cells.
| NATURE COMMUNICATIONS |
2016 | Usefulness of Measuring Serum Procalcitonin Levels in Patients with Inflammatory Bowel Disease.
| GUT AND LIVER |
2019 | ZNF133 is associated with infliximab responsiveness in patients with inflammatory bowel diseases | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |